This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Colapinto, E. V. Articles by Bigner, D. D. Search for Related Content PubMed PubMed Citation Articles by Colapinto, E. V. Articles by Bigner, D. D.

Comparative Localization of Murine Monoclonal Antibody Me1-14 F(ab')₂ Fragment and Whole IgG2a in Human Glioma Xenografts¹

Departments of Pathology [E. V. C., P. A. H., M. R. Z., D. D. B.] Pediatrics [H. S. F.], and Radiology [M. R. Z.] and the Preuss Laboratory for Brain Tumor Research [D. D. B.], Duke University Medical Center, Durham, North Carolina 27710; Department of Neurology, Northwestern University Medical School, Evanston Hospital, Evanston, Illinois 60201 [D. R. G.]; Department of Neurosurgery, Central University Hospital Vaudois, CH-1011 Lausanne, Switzerland [N. T.]; and Ludwig Institute for Cancer Research, Lausanne Branch, CH-1066 Epalinges, Switzerland [S. C.]

Monoclonal antibodies (MAbs) targeted to glioma-associated antigens may allow the selective delivery of imaging and therapeutic agents to brain tumors; the use of MAb fragments may be a strategy to further improve tumor uptake of such agents relative to normal tissues. In this study, we have examined the in vivo localization of radioiodinated MAb Me1-14, a murine immunoglobulin G2a (IgG2a) reactive with gliomas, and its F(ab')₂ fragment in s.c. and intracranial xenografts of human glioma cell line D-54 MG in athymic mice. The radiolabeled F(ab')₂ fragment of Me1-14 was demonstrated to possess in vitro binding affinity and immunoreactivity comparable to that of whole IgG. Direct comparison of IgG and F(ab')₂ biodistribution in s. c. xenograft-bearing mice showed higher tumor: normal tissue ratios of the F(ab')₂ fragment compared to IgG. In intracranial tumor-bearing mice paired-label analysis using a nonspecific protein control showed earlier specific tumor localization by the F(ab')₂ fragment of Me1-14 compared to IgG. Blood-to-tumor transfer constants (K₁) derived for Me1-14 F(ab')₂ were significantly greater than those for whole Me1-14 (P = 0.01). Estimated radiation dosimetry revealed that ¹³¹I-labeled Me1-14 F(ab')₂ would deliver higher radiation doses to tumor than to normal tissues. These studies demonstrate that the F(ab')₂ fragment of Me1-14 may be a potential agent for immune-directed brain tumor diagnosis and therapy.

¹ This work was supported by NIH Grants CA42324, CA11898, CA32672, CA44640, NS12745, NS20023, K07NS00958, K04NS00814, and ACS CH403.

² Recipient of a Fellowship of the Medical Research Council of Canada.

³ To whom requests for reprints should be addressed, at Box 3156, Duke University Medical Center, Durham, NC 27710.

Received 3/25/88. Revised 6/24/88. Accepted 7/18/88.

This article has been cited by other articles:

				D. Shan, O. W. Press, T. T. Tsu, M. S. Hayden, and J. A. Ledbetter Characterization of scFv-Ig Constructs Generated from the Anti-CD20 mAb 1F5 Using Linker Peptides of Varying Lengths J. Immunol., June 1, 1999; 162(11): 6589 - 6595. [Abstract] [Full Text] [PDF]